PTC Therapeutics Cash Flow Statement
NASDAQ: PTCTHealth CareBiotechnology: Pharmaceutical PreparationsUSD
64.70+2.14 (+3.42%)
At close: Oct 9, 4:00 PM ET · Delayed 15 min
PTC Therapeutics free cash flow
In fiscal 2025, PTC Therapeutics generated $711.2 million of operating cash flow and spent $8.9 million on capital expenditures. That left free cash flow of $702.3 million, a free-cash-flow margin of 40.6% of revenue.
Summary generated from market data by MetaCap's automated system. Methodology
PTC Therapeutics cash flow statement (annual)
| Fiscal year (USD) | FY 20252025-12-31 | FY 20242024-12-31 | FY 20232023-12-31 | FY 20222022-12-31 | FY 20212021-12-31 | FY 20202020-12-31 | FY 20192019-12-31 | FY 20182018-12-31 | FY 20172017-12-31 | FY 20162016-12-31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Net Income | 682.64M | -363.30M | -626.60M | -559.02M | -523.90M | -438.16M | -251.58M | -128.08M | -79.00M | -142.11M |
| Net Income growth (YoY) | — | — | — | — | — | — | — | — | — | — |
| Depreciation & Amortization | 38.81M | 75.66M | 236.59M | 128.84M | 64.13M | 43.49M | 32.18M | 26.09M | 17.68M | 3.29M |
| Stock-Based Compensation | 74.55M | 74.61M | 101.64M | 110.33M | 103.51M | 70.33M | 42.13M | 33.25M | 30.56M | 35.01M |
| Change in Working Capital | -50.52M | 90.08M | -9.22M | -82.42M | -23.56M | 38.74M | 20.91M | 15.30M | 13.77M | -7.89M |
| Operating Cash Flow | 711.20M | -107.69M | -158.42M | -356.65M | -251.33M | -194.07M | -98.64M | -27.64M | -10.06M | -103.57M |
| Capital Expenditures | -8.86M | -6.50M | -28.44M | -32.02M | -28.21M | -17.84M | -13.76M | -7.10M | -3.10M | -1.78M |
| Investing Cash Flow | -861.98M | 44.18M | -176.74M | 290.18M | 219.18M | -561.55M | -387.24M | -42.61M | 13.12M | 104.48M |
| Debt Repaid | — | — | — | — | — | — | — | — | — | 0 |
| Financing Cash Flow | 331.09M | 255.87M | 646.40M | 167.95M | 20.88M | 668.72M | 613.21M | 131.57M | 44.22M | 968.00K |
| Net Change in Cash | 203.02M | 185.03M | 314.36M | 98.71M | -19.09M | -79.22M | 126.03M | 57.71M | 53.47M | 299.00K |
| Free Cash Flow | 702.34M | -114.19M | -186.86M | -388.67M | -279.55M | -211.91M | -112.40M | -34.74M | -13.16M | -105.34M |
This table shows 10 annual periods of PTC Therapeutics's cash flow statement, from FY 2025 back to FY 2016, across 11 line items including net income, depreciation & amortization, stock-based compensation. Values in USD; B = billions, M = millions. Fiscal periods follow PTCT's reporting calendar. What is a cash flow statement?